Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q3
$3.02M Buy
89,024
+1,985
+2% +$63.8K 0.3% 49
2017
Q2
$2.77M Buy
87,039
+1,730
+2% +$54.6K 0.28% 52
2017
Q1
$2.77M Buy
85,309
+807
+1% +$25.4K 0.29% 49
2016
Q4
$2.6M Buy
84,502
+6,375
+8% +$195K 0.29% 50
2016
Q3
$2.51M Buy
78,127
+2,788
+4% +$93.2K 0.27% 49
2016
Q2
$2.52M Buy
75,339
+1,547
+2% +$49.4K 0.28% 49
2016
Q1
$2.08M Buy
73,792
+56,648
+330% +$1.62M 0.25% 58
2015
Q4
$525K Sell
17,144
-3,560
-17% -$112K 0.06% 129
2015
Q3
$617K Buy
20,704
+1,913
+10% +$61.3K 0.08% 116
2015
Q2
$597K Buy
18,791
+5,181
+38% +$169K 0.07% 122
2015
Q1
$449K Sell
13,610
-177
-1% -$5.63K 0.05% 139
2014
Q4
$408K Sell
13,787
-8,895
-39% -$255K 0.04% 154
2014
Q3
$637K Sell
22,682
-689
-3% -$19.3K 0.07% 121
2014
Q2
$658K Buy
23,371
+1,902
+9% +$54.2K 0.07% 121
2014
Q1
$654K Buy
21,469
+7,722
+56% +$230K 0.07% 119
2013
Q4
$399K Buy
13,747
+160
+1% +$4.66K 0.04% 161
2013
Q3
$370K Sell
13,587
-759
-5% -$20.7K 0.04% 157
2013
Q2
$381K Buy
+14,346
New +$396K 0.05% 153

Other funds holding PFE

BancorpSouth's PFE Position: Q3 2017 in Review

BancorpSouth increased its Pfizer (PFE) stake by 2.3% in Q3 2017, buying an estimated $63.8K and bringing the position to 89,024 shares worth $3.02M. The position accounts for 0.3% of the portfolio, ranked #49.

BancorpSouth first reported a position in PFE in Q2 2013 and has held it in 18 quarters since. 2,040 funds tracked by Wall St. Rank hold PFE as of Q3 2017.

  • BancorpSouth held 89,024 shares of Pfizer worth $3.02M as of Q3 2017.
  • BancorpSouth bought 1,985 Pfizer shares in Q3 2017, an estimated $63.8K.
  • Pfizer made up 0.3% of BancorpSouth's portfolio in Q3 2017, its #49 holding.
  • BancorpSouth first reported a position in Pfizer in Q2 2013 and has held it in 18 quarters since.
  • 2,040 funds tracked by Wall St. Rank held Pfizer as of Q3 2017.

Based on BancorpSouth's 13F filing for Q3 2017, filed 14 Nov 2017.